chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Sore throat; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore throat). At the time of the report, OROPHARYNGEAL PAIN (Sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: worsen arthritis; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (worsen arthritis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (worsen arthritis). At the time of the report, ARTHRITIS (worsen arthritis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient's arthritis was worsen after the vaccine.  No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: we have a patient who was completely vaccinated but showing Covid symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (we have a patient who was completely vaccinated but showing Covid symptoms) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (we have a patient who was completely vaccinated but showing Covid symptoms). At the time of the report, COVID-19 (we have a patient who was completely vaccinated but showing Covid symptoms) outcome was unknown.            No relevant concomitant medications were reported. Treatment information was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Feel nauseous; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Feel nauseous) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Feel nauseous). At the time of the report, NAUSEA (Feel nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: extremely fatigued; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extremely fatigued) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not provided) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (extremely fatigued). At the time of the report, FATIGUE (extremely fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Erythema, Feeling hot, Hypotension, Inflammation
Clinical narrative: itchy arm; redness; feeling of warmth; Inflammation; Sleep difficult; had low blood pressure for a week, 84/48, 94/52; arm is swollen; pain in arm; rash on the injection site; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (itchy arm), ERYTHEMA (redness), FEELING HOT (feeling of warmth), INFLAMMATION (Inflammation) and INSOMNIA (Sleep difficult) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchy arm), ERYTHEMA (redness), FEELING HOT (feeling of warmth), INFLAMMATION (Inflammation), INSOMNIA (Sleep difficult), HYPOTENSION (had low blood pressure for a week, 84/48, 94/52), PERIPHERAL SWELLING (arm is swollen), PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE RASH (rash on the injection site). At the time of the report, PRURITUS (itchy arm), ERYTHEMA (redness), FEELING HOT (feeling of warmth), INFLAMMATION (Inflammation), INSOMNIA (Sleep difficult), HYPOTENSION (had low blood pressure for a week, 84/48, 94/52), PERIPHERAL SWELLING (arm is swollen), PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE RASH (rash on the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 84/48 (Low) 84/48 and 94/52 (normal) 94/52.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant and  treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow up received contains no new information On 13-Jul-2021: Follow up received contains no new inform,ation
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pain in extremity, Peripheral swelling, Pruritus, Vaccination site rash
Clinical narrative: itchy arm; redness; feeling of warmth; Inflammation; Sleep difficult; had low blood pressure for a week, 84/48, 94/52; arm is swollen; pain in arm; rash on the injection site; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (itchy arm), ERYTHEMA (redness), FEELING HOT (feeling of warmth), INFLAMMATION (Inflammation) and INSOMNIA (Sleep difficult) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchy arm), ERYTHEMA (redness), FEELING HOT (feeling of warmth), INFLAMMATION (Inflammation), INSOMNIA (Sleep difficult), HYPOTENSION (had low blood pressure for a week, 84/48, 94/52), PERIPHERAL SWELLING (arm is swollen), PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE RASH (rash on the injection site). At the time of the report, PRURITUS (itchy arm), ERYTHEMA (redness), FEELING HOT (feeling of warmth), INFLAMMATION (Inflammation), INSOMNIA (Sleep difficult), HYPOTENSION (had low blood pressure for a week, 84/48, 94/52), PERIPHERAL SWELLING (arm is swollen), PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE RASH (rash on the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 84/48 (Low) 84/48 and 94/52 (normal) 94/52.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant and  treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow up received contains no new information On 13-Jul-2021: Follow up received contains no new inform,ation
Sex: U
Vaccine: COVID19
Symptoms: Polyuria
Clinical narrative: Started to pee a lot after the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of POLYURIA (Started to pee a lot after the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced POLYURIA (Started to pee a lot after the vaccine). At the time of the report, POLYURIA (Started to pee a lot after the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported.  No treatment medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headaches; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Headaches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headaches). At the time of the report, HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Throwing up; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Throwing up) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (Throwing up). At the time of the report, VOMITING (Throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant  and treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Nausea after the 2nd dose; Blossoming headache after the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea after the 2nd dose) and HEADACHE (Blossoming headache after the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea after the 2nd dose) and HEADACHE (Blossoming headache after the 2nd dose). At the time of the report, NAUSEA (Nausea after the 2nd dose) and HEADACHE (Blossoming headache after the 2nd dose) outcome was unknown.            No concomitant medications were reported No treatment drugs were reported
Sex: U
Vaccine: COVID19
Symptoms: Pneumonia
Clinical narrative: Pneumonia; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (Pneumonia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (Pneumonia). At the time of the report, PNEUMONIA (Pneumonia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided.  Treatment information was not provided.  Company Comment: Very limited information regarding this event has been provided at this time. No further information is expected at this time.; Sender's Comments: Very limited information regarding this event has been provided at this time. No further information is expected at this time.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Pain in the arm; Headache; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Pain in the arm), HEADACHE (Headache) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Pain in the arm), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, MYALGIA (Pain in the arm), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Oral discomfort
Clinical narrative: Burning in the mouth; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ORAL DISCOMFORT (Burning in the mouth) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ORAL DISCOMFORT (Burning in the mouth). At the time of the report, ORAL DISCOMFORT (Burning in the mouth) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment medications reported.
Sex: U
Vaccine: COVID19
Symptoms: Cold sweat, Hyperhidrosis
Clinical narrative: cold sweat; hot sweat; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweat) and HYPERHIDROSIS (hot sweat) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COLD SWEAT (cold sweat) and HYPERHIDROSIS (hot sweat). At the time of the report, COLD SWEAT (cold sweat) and HYPERHIDROSIS (hot sweat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: had an adverse reaction/ ended up in the ER; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (had an adverse reaction/ ended up in the ER) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (had an adverse reaction/ ended up in the ER). At the time of the report, ADVERSE REACTION (had an adverse reaction/ ended up in the ER) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided.  No concomitant medication were provided.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event, Illness
Clinical narrative: Feel sick with side effects after the 2nd dose; Feel sick with side effects after the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Feel sick with side effects after the 2nd dose) and ADVERSE EVENT (Feel sick with side effects after the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Feel sick with side effects after the 2nd dose) and ADVERSE EVENT (Feel sick with side effects after the 2nd dose). At the time of the report, ILLNESS (Feel sick with side effects after the 2nd dose) and ADVERSE EVENT (Feel sick with side effects after the 2nd dose) outcome was unknown.            No information about concomitants was provided.  No information about treatment medication was provided.
Sex: U
Vaccine: COVID19
Symptoms: Gastroenteritis viral, Suspected COVID-19
Clinical narrative: Stomach virus after the 1st dose; False positive COVID-19 test; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 31-May-2021 and was forwarded to Moderna on 01-Jun-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of GASTROENTERITIS VIRAL (Stomach virus after the 1st dose) and SUSPECTED COVID-19 (False positive COVID-19 test) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GASTROENTERITIS VIRAL (Stomach virus after the 1st dose) and SUSPECTED COVID-19 (False positive COVID-19 test). At the time of the report, GASTROENTERITIS VIRAL (Stomach virus after the 1st dose) and SUSPECTED COVID-19 (False positive COVID-19 test) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported. Treatment medication was not reported.  patient wanted to know if a false positive show up because of getting the vaccine last week.
Sex: U
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Insomnia, Sleep disorder
Clinical narrative: Having sleeping problem; sleeplessness; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (Having sleeping problem ) and INSOMNIA (sleeplessness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SLEEP DISORDER (Having sleeping problem ) and INSOMNIA (sleeplessness). At the time of the report, SLEEP DISORDER (Having sleeping problem ) and INSOMNIA (sleeplessness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Breath odour, Sinus disorder, Upper-airway cough syndrome
Clinical narrative: I notice it has an odor; Sinuses start to run occasionally; Post nasal drip; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BREATH ODOUR (I notice it has an odor), SINUS DISORDER (Sinuses start to run occasionally) and UPPER-AIRWAY COUGH SYNDROME (Post nasal drip) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BREATH ODOUR (I notice it has an odor), SINUS DISORDER (Sinuses start to run occasionally) and UPPER-AIRWAY COUGH SYNDROME (Post nasal drip). At the time of the report, BREATH ODOUR (I notice it has an odor), SINUS DISORDER (Sinuses start to run occasionally) and UPPER-AIRWAY COUGH SYNDROME (Post nasal drip) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Contusion, Limb discomfort
Clinical narrative: my arm is bruised; can't really move arm; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (my arm is bruised) and LIMB DISCOMFORT (can't really move arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONTUSION (my arm is bruised) and LIMB DISCOMFORT (can't really move arm). At the time of the report, CONTUSION (my arm is bruised) and LIMB DISCOMFORT (can't really move arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided  No Treatment medications were provided   This case was linked to MOD-2021-240107 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: I have a lingering cough that has been going on since I received the vaccine.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (I have a lingering cough that has been going on since I received the vaccine.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (I have a lingering cough that has been going on since I received the vaccine.). At the time of the report, COUGH (I have a lingering cough that has been going on since I received the vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: vomiting; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (vomiting). At the time of the report, VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drug was provided.  No treatment drug was provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Injection site is red and hot; injection site is very red; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site is red and hot) and VACCINATION SITE ERYTHEMA (injection site is very red) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site is red and hot) and VACCINATION SITE ERYTHEMA (injection site is very red). At the time of the report, VACCINATION SITE WARMTH (Injection site is red and hot) and VACCINATION SITE ERYTHEMA (injection site is very red) outcome was unknown.            No concomitant and treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history is provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided.  No concomitant medication were provided.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment medications were not provided.   Reporter did not allow further contact
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: a second episode of body ach9; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (a second episode of body ach9) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (a second episode of body ach9). At the time of the report, MYALGIA (a last episode of body ach9) outcome was unknown.            No treatment medications were provided No concomitant medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: feeling dizzy and nausea; feeling dizzy and nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feeling dizzy and nausea) and NAUSEA (feeling dizzy and nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (feeling dizzy and nausea) and NAUSEA (feeling dizzy and nausea). At the time of the report, DIZZINESS (feeling dizzy and nausea) and NAUSEA (feeling dizzy and nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported  No treatment medications reported
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site mass
Clinical narrative: Hard lump on the arm of the injection/hard lump on my injection arm; Hard lump on the arm of the injection/hard lump on my injection arm; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MASS (Hard lump on the arm of the injection/hard lump on my injection arm) and VACCINATION SITE INDURATION (Hard lump on the arm of the injection/hard lump on my injection arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (Hard lump on the arm of the injection/hard lump on my injection arm) and VACCINATION SITE INDURATION (Hard lump on the arm of the injection/hard lump on my injection arm). At the time of the report, VACCINATION SITE MASS (Hard lump on the arm of the injection/hard lump on my injection arm) and VACCINATION SITE INDURATION (Hard lump on the arm of the injection/hard lump on my injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Dysgeusia, Myalgia, Night sweats
Clinical narrative: Bad sweats on the 3rd night; Heavy metallic taste a few hrs after the vaccine/became increasingly heavy the next day which lasted two days; I needed up bad aches for 24 hours the day after; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Bad sweats on the 3rd night), DYSGEUSIA (Heavy metallic taste a few hrs after the vaccine/became increasingly heavy the next day which lasted two days) and MYALGIA (I needed up bad aches for 24 hours the day after) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NIGHT SWEATS (Bad sweats on the 3rd night), DYSGEUSIA (Heavy metallic taste a few hrs after the vaccine/became increasingly heavy the next day which lasted two days) and MYALGIA (I needed up bad aches for 24 hours the day after). At the time of the report, NIGHT SWEATS (Bad sweats on the 3rd night), DYSGEUSIA (Heavy metallic taste a few hrs after the vaccine/became increasingly heavy the next day which lasted two days) and MYALGIA (I needed up bad aches for 24 hours the day after) outcome was unknown.            No treatment medication were reported.
Sex: U
Vaccine: COVID19
Symptoms: Angioedema, Arthralgia, Histone antibody, Joint swelling, Myalgia
Clinical narrative: swelling; joint pain; angioedema; throat closing up; muscle pain from head to toe; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ANGIOEDEMA (angioedema), THROAT TIGHTNESS (throat closing up), JOINT SWELLING (swelling), ARTHRALGIA (joint pain) and MYALGIA (muscle pain from head to toe) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (muscle pain from head to toe). On 19-Mar-2021, the patient experienced ANGIOEDEMA (angioedema) and THROAT TIGHTNESS (throat closing up). On 07-May-2021, the patient experienced JOINT SWELLING (swelling) and ARTHRALGIA (joint pain). At the time of the report, ANGIOEDEMA (angioedema), THROAT TIGHTNESS (throat closing up), JOINT SWELLING (swelling), ARTHRALGIA (joint pain) and MYALGIA (muscle pain from head to toe) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-May-2021, Histone antibody: high (Positive) histone antibodies were high. On 07-May-2021, Protein S: increased (High) spiked proteins were extremely high.         No concomitant medication information was provided.  5 weeks later, patient developed angioedema and throat closing up. Then 7 weeks later, patient developed joint pain and swelling.  No treatment medication information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Protein S, Throat tightness
Clinical narrative: swelling; joint pain; angioedema; throat closing up; muscle pain from head to toe; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ANGIOEDEMA (angioedema), THROAT TIGHTNESS (throat closing up), JOINT SWELLING (swelling), ARTHRALGIA (joint pain) and MYALGIA (muscle pain from head to toe) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (muscle pain from head to toe). On 19-Mar-2021, the patient experienced ANGIOEDEMA (angioedema) and THROAT TIGHTNESS (throat closing up). On 07-May-2021, the patient experienced JOINT SWELLING (swelling) and ARTHRALGIA (joint pain). At the time of the report, ANGIOEDEMA (angioedema), THROAT TIGHTNESS (throat closing up), JOINT SWELLING (swelling), ARTHRALGIA (joint pain) and MYALGIA (muscle pain from head to toe) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-May-2021, Histone antibody: high (Positive) histone antibodies were high. On 07-May-2021, Protein S: increased (High) spiked proteins were extremely high.         No concomitant medication information was provided.  5 weeks later, patient developed angioedema and throat closing up. Then 7 weeks later, patient developed joint pain and swelling.  No treatment medication information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.            No concomitant medication was provided  No treatment medication was provided  patient want to knowhow long does dizziness last??? It's been over a month from patient  2nd shot.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Myalgia
Clinical narrative: left arm pain that goes into my chest; left arm pain that goes into my chest; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (left arm pain that goes into my chest) and MYALGIA (left arm pain that goes into my chest) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (left arm pain that goes into my chest) and MYALGIA (left arm pain that goes into my chest). At the time of the report, CHEST PAIN (left arm pain that goes into my chest) and MYALGIA (left arm pain that goes into my chest) outcome was unknown.            No concomitant medication was reported ,  no treatment medication was reported . for mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessment. action taken with mRNA-1273 (COVID 19 Vaccine Moderna)(unknown), was not applicable
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Rash
Clinical narrative: rash on my abdomen; chills; aches; headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on my abdomen), CHILLS (chills), MYALGIA (aches) and HEADACHE (headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-May-2021, the patient experienced CHILLS (chills), MYALGIA (aches) and HEADACHE (headache). On 31-May-2021, the patient experienced RASH (rash on my abdomen). At the time of the report, RASH (rash on my abdomen), CHILLS (chills), MYALGIA (aches) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment drugs were reported
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joint Pain / Had the 2nd dose in February but didnt start with joint pain until April; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint Pain / Had the 2nd dose in February but didnt start with joint pain until April) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Joint Pain / Had the 2nd dose in February but didnt start with joint pain until April). At the time of the report, ARTHRALGIA (Joint Pain / Had the 2nd dose in February but didnt start with joint pain until April) outcome was unknown.            Patient has not experienced joint pain until April .  No concomitant medications were reported. No treatment medications were reported.
Age: 20.0
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches) in a 20-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-May-2021, the patient experienced MYALGIA (body aches). At the time of the report, MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.